NCIMB
Private Company
Funding information not available
Overview
NCIMB is a long-established, service-oriented microbiology company headquartered in Aberdeen, UK. Its core assets are the UK's largest public repository of bacterial reference strains and a comprehensive suite of analytical and storage services. The company serves a diverse client base in pharmaceuticals, agriculture, food & drink, energy, and environmental services, positioning itself as a critical support partner in the microbiome and synthetic biology ecosystems.
Technology Platform
Integrated microbiology services platform centered on a proprietary microbial culture collection, complemented by analytical services (ID, sequencing, qPCR, metagenomics), preservation/storage, and proprietary ecotoxicity tests (MARA, LumiMARA).
Opportunities
Risk Factors
Competitive Landscape
NCIMB competes with other global culture collections (e.g., ATCC, DSMZ), commercial microbiology testing laboratories, and CROs offering microbial services. Its differentiation lies in the combination of its unique, industry-focused strain collection, its breadth of services from storage to advanced sequencing, and its niche proprietary ecotoxicity tests. It faces pressure from automation and the trend toward bringing simple ID and sequencing capabilities in-house.